Warning letter
Ridge Properties, LLC: warning letter of Oct 13, 2017
FDA warning letter 525794 · Los Angeles District Office
Key facts
| Reference number | 525794 |
|---|---|
| Company | Ridge Properties, LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug |
| Issue date | Oct 13, 2017 |
| Posted date | Oct 13, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.198(a), 211.34, 211.188, 330.1, 201.66(b)(2), 201.66(c)(5)(i), 346, 201.1, 211.22(a), 211.42(c), 211.100(a), 211.165(a) and 1 more |
| Inspection city | Salem |
| Inspection ZIP | 97301 |
| Inspection start date | Feb 28, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: